Better Therapeutics

Better Therapeutics is a privately held company located in San Francisco, California. The company employs 21 people. Better Therapeutics is a prescription digital therapeutics (PDT) company that develops software-based solutions for treating cardiometabolic diseases. Their proprietary platform delivers cognitive behavioral therapy (CBT) through mobile applications intended to be prescribed by physicians and reimbursed like traditional medicines. The company's products are designed to address the root causes of type 2 diabetes, heart disease, hypertension, and hyperlipidemia by enabling lasting changes in behavior through changes in neural pathways. Better Therapeutics' clinically validated mobile applications are currently in development for type 2 diabetes, hypertension, and hyperlipidemia. The company is currently enrolling patients in a pivotal trial for BT-001, an investigational therapeutic for type 2 diabetes. For more information about Better Therapeutics, please visit their website at www.bettertx.com.